Skip to main content

Table 3 Linear regression analysis of the association between CKD treatments and the serum CRP concentration #

From: Effect of erythropoietin-stimulating agent on uremic inflammation

Factor Regression coefficient 95%CI p value
ESA −0.111 −0.274 - -0.065 0.0015
ESA dose −0.117 −0.014 - -0.003 0.0017
ARB −0.076 −0.196 - -0.012 0.0275
ACE-I −0.061 −0.221 - 0.012 0.0785
ARB or ACE-I −0.083 −0.212 - -0.022 0.0154
ARB and ACE-I −0.065 −0.267 - 0.005 0.0589
CCB −0.1 −0.241 - -0.046 0.0039
other anti-HT −0.068 −0.188 - 0.001 0.0515
AT-120 −0.041 −0.190 - 0.046 0.2306
Vitamin D −0.064 −0.220 - 0.007 0.0664
Fe −0.086 −0.334 - 0.003 0.054
  1. # All factors are adjusted by the "duration of nephrologist care"
  2. ESA; erythropoietin-stimulating agents, ARB; angiotensin-II receptor blockers, ACE-I; angiotensin-converting enzyme inhibitors, CCB; calcium channel blockers, anti-HT; antihypertensive.